208 related articles for article (PubMed ID: 2196116)
1. Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice.
Giavazzi R; Garofalo A; Bani MR; Abbate M; Ghezzi P; Boraschi D; Mantovani A; Dejana E
Cancer Res; 1990 Aug; 50(15):4771-5. PubMed ID: 2196116
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 1 receptor antagonist inhibits the augmentation of metastasis induced by interleukin 1 or lipopolysaccharide in a human melanoma/nude mouse system.
Chirivi RG; Garofalo A; Padura IM; Mantovani A; Giavazzi R
Cancer Res; 1993 Oct; 53(20):5051-4. PubMed ID: 8267795
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
Huang S; Xie K; Bucana CD; Ullrich SE; Bar-Eli M
Clin Cancer Res; 1996 Dec; 2(12):1969-79. PubMed ID: 9816156
[TBL] [Abstract][Full Text] [Related]
4. Endothelial expression of vascular cell adhesion molecule-1 correlates with metastatic pattern in spontaneous melanoma.
Langley RR; Carlisle R; Ma L; Specian RD; Gerritsen ME; Granger DN
Microcirculation; 2001 Oct; 8(5):335-45. PubMed ID: 11687945
[TBL] [Abstract][Full Text] [Related]
5. Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient.
Doucet C; Meazza R; Pottin-Clemenceau C; Scudeletti M; Brouty-Boye D; Ferrini S; Alileche A; Taoufik Y; Jasmin C; Azzarone B; Indiveri F
Melanoma Res; 1997 Aug; 7 Suppl 2():S7-17. PubMed ID: 9578412
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastases.
Garofalo A; Chirivi RG; Foglieni C; Pigott R; Mortarini R; Martin-Padura I; Anichini A; Gearing AJ; Sanchez-Madrid F; Dejana E
Cancer Res; 1995 Jan; 55(2):414-9. PubMed ID: 7529137
[TBL] [Abstract][Full Text] [Related]
7. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
[TBL] [Abstract][Full Text] [Related]
8. Regulation of interleukin-8 expression in human melanoma cells by the organ environment.
Gutman M; Singh RK; Xie K; Bucana CD; Fidler IJ
Cancer Res; 1995 Jun; 55(11):2470-5. PubMed ID: 7758001
[TBL] [Abstract][Full Text] [Related]
9. Effect of ultraviolet-inducible cytokines on melanoma growth in vivo: stimulation of melanoma growth by interleukin-1 and -6.
Mckenzie RC; Park ES; Brown WR; Shivji GS; Sauder DN
Photodermatol Photoimmunol Photomed; 1994 Apr; 10(2):74-9. PubMed ID: 8043388
[TBL] [Abstract][Full Text] [Related]
10. A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice.
Kozlowski JM; Hart IR; Fidler IJ; Hanna N
J Natl Cancer Inst; 1984 Apr; 72(4):913-7. PubMed ID: 6584666
[TBL] [Abstract][Full Text] [Related]
11. Decrease in interleukin 2-induced vascular leakage in the lungs of mice by administration of recombinant interleukin 1 alpha in vivo.
Puri RK; Travis WD; Rosenberg SA
Cancer Res; 1989 Feb; 49(4):969-76. PubMed ID: 2783561
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor.
Pötgens AJ; van Altena MC; Lubsen NH; Ruiter DJ; de Waal RM
Am J Pathol; 1996 Apr; 148(4):1203-17. PubMed ID: 8644861
[TBL] [Abstract][Full Text] [Related]
13. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ
Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
[TBL] [Abstract][Full Text] [Related]
14. Extrapulmonary, tissue-specific metastasis formation in nude mice injected with FEMX-I human melanoma cells.
Fodstad O; Kjønniksen I; Aamdal S; Nesland JM; Boyd MR; Pihl A
Cancer Res; 1988 Aug; 48(15):4382-8. PubMed ID: 3390834
[TBL] [Abstract][Full Text] [Related]
15. Organ-specific metastases in immunodeficient mice injected with human melanoma cells: a quantitative pathological analysis.
Byers HR; Etoh T; Lee KW; Mihm MC; Gattoni-Celli S
Melanoma Res; 1993 Aug; 3(4):247-53. PubMed ID: 8219757
[TBL] [Abstract][Full Text] [Related]
16. In vivo destruction of tumor tissue by cryoablation can induce inhibition of secondary tumor growth: an experimental study.
Joosten JJ; Muijen GN; Wobbes T; Ruers TJ
Cryobiology; 2001 Feb; 42(1):49-58. PubMed ID: 11336489
[TBL] [Abstract][Full Text] [Related]
17. Enhanced tumor uptake of macromolecules induced by a novel vasoactive interleukin 2 immunoconjugate.
LeBerthon B; Khawli LA; Alauddin M; Miller GK; Charak BS; Mazumder A; Epstein AL
Cancer Res; 1991 May; 51(10):2694-8. PubMed ID: 2021947
[TBL] [Abstract][Full Text] [Related]
18. Regulation of interleukin 8 expression in human malignant melanoma cells.
Singh RK; Varney ML
Cancer Res; 1998 Apr; 58(7):1532-7. PubMed ID: 9537260
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of tumor metastasis by platelet-activating factor.
Im SY; Ko HM; Kim JW; Lee HK; Ha TY; Lee HB; Oh SJ; Bai S; Chung KC; Lee YB; Kang HS; Chun SB
Cancer Res; 1996 Jun; 56(11):2662-5. PubMed ID: 8653713
[TBL] [Abstract][Full Text] [Related]
20. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases.
Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L
Cancer Res; 1995 Nov; 55(21):4941-9. PubMed ID: 7585534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
